Manama, Dr. Ahmed Mohammed Al Ansari, Chief Executive of the National Health Regulatory Authority (NHRA), and Dr. Hisham Saad Al Jadhey, CEO of Saudi Food and Drug Authority (SFDA), signed a Memorandum of Understanding (MoU) to enhance collaboration on the approval of pharmaceuticals and medical devices between Bahrain and Saudi Arabia. The signing was attended by Lieutenant General Dr. Shaikh Mohamed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health (SCH). Dr. Al Ansari affirmed that this agreement strengthens cooperation between the two authorities, enabling Bahrain to recognise and approve pharmaceutical products and medical devices already authorised by Saudi Arabia's SFDA. He added that the MoU will allow for smoother regulatory processes by aligning standards for pharmaceuticals and medical devices approved by the SFDA, supporting the health sector in both countries. The NHRA and SFDA have signed an agreement in 2019. Source: Bahrain News Agency
Related Posts
Jordan: 10 lists out of 25 win seats allocated to parties
Amman – Ma’an – Ten general lists won the 41 seats allocated to parties in Jordan, after 25 candidate lists competed, 5 of which represent party alliances, and 20 lists represent individual parties.
Seventeen candidates from the Islamic Action Front …
Qatar Calls for Urgent International Action to Spare Middle East Full-Scale of New Vortex of Conflicts
The State of Qatar has urged the international community to immediately act to defuse the tension and spare the Middle East region the peril of being dragged into a new vortex of conflicts. It urged all parties to de-escalate the situation and exerci…
UNRWA Deputy Commissioner-General: Efforts to dismantle UNRWA are still ongoing
The Deputy Commissioner-General of UNRWA said that the Security Council issued resolutions to end the war, but they had no effect, and the suffering in the Gaza Strip is increasing.
She pointed out that “two-thirds of UNRWA’s facilities and installa…